LifeStance Health (LFST) Other Operating Expenses (2020 - 2026)

LifeStance Health (LFST) has reported Other Operating Expenses for 7 consecutive years, with $280.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 18.54% year-over-year to $280.9 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 111.79% YoY), while the FY2025 annual figure was $1.0 billion, up 10.7% from the prior year.
• Other Operating Expenses rose to $280.9 million in Q1 2026 per LFST's latest filing, from $269.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $280.9 million in Q1 2026 and bottomed at $15.1 million in Q3 2024.
• Historically, Other Operating Expenses has averaged $102.1 million across 5 years, with a median of $19.6 million in 2023.
• Annual changes were most pronounced in 2024 — Other Operating Expenses slipped 22.97% — and 2025, when it surged 1625.33%.
• LifeStance Health's Other Operating Expenses stood at $18.9 million in 2022, then gained by 17.63% to $22.2 million in 2023, then soared by 938.46% to $230.7 million in 2024, then increased by 16.74% to $269.3 million in 2025, then increased by 4.28% to $280.9 million in 2026.
• Business Quant data shows LFST's Other Operating Expenses at $280.9 million in Q1 2026, $269.3 million in Q4 2025, and $260.8 million in Q3 2025.